Key result
Diabetic cardiovascular autonomic neuropathy is linked to silent MI, orthostasis, and increased mortality risk.
Why the study?
Cardiovascular autonomic neuropathy is an overlooked serious complication of diabetes with significant clinical manifestations and potentially life-threatening outcomes.
O ne of the most overlooked of all serious complications of diabetes is cardiovascular autonomic neuropathy (CAN), he present report discusses the clinical manifestations (eg, resting tachycardia, orthostasis, exercise intolerance, intraoperative cardiovascular liability, silent myocardial infarction [MI], and increased risk of mortality) in the presence of CAN. It also demonstrates that autonomic dysfunction can affect daily activities of individuals with diabetes and may invoke potentially life-threatening outcomes. Advances in technology, built on decades of research and clinical testing, now make it possible to objectively identify early stages of CAN with the use of careful measurement of autonomic function and to provide therapeutic choices that are based on symptom control and that might abrogate the underlying disorder.
No takes yet. Share an insight, caveat, or question.
Vinik et al. (2007) conducted a review in Diabetic Cardiovascular Autonomic Neuropathy. Cardiovascular autonomic neuropathy was evaluated. Cardiovascular autonomic neuropathy is a serious complication of diabetes associated with resting tachycardia, orthostasis, silent myocardial infarction, and increased risk of mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: